You are Here : Moneycontrol Forum Forum Topics Stocks

Sun Pharma

Diana Horton
Gold Member

1939 Messages

Net income plunged 59 percent to 9.12 billion rupees ($139 million) in the quarter through September, the Mumbai-based company said Tuesday. Analysts had expected profit to decline to 8 billion rupees. U.S. sales, which fell 44 percent in the quarter, are not comparable with a year earlier because it has since lost exclusive rights for the generic version of a blockbuster cancer drug, according to a separate statement.

12.57 AM Nov 15th
I agree to the M3 code of conduct


Get your own permanent - nickname

Choose your nickname

Your permanent Nickname can be distinct from your username and no one need know the link between the two.

Follow us on
Available On